GIANNECCHINI, SIMONE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.813
EU - Europa 4.361
AS - Asia 3.511
SA - Sud America 511
Continente sconosciuto - Info sul continente non disponibili 218
AF - Africa 113
OC - Oceania 67
Totale 16.594
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.685
RU - Federazione Russa 1.569
IT - Italia 1.041
SG - Singapore 947
CN - Cina 818
HK - Hong Kong 636
BR - Brasile 403
PL - Polonia 348
VN - Vietnam 345
IE - Irlanda 331
KR - Corea 287
SE - Svezia 232
UA - Ucraina 186
DE - Germania 169
FI - Finlandia 135
GB - Regno Unito 129
FR - Francia 127
JO - Giordania 126
IN - India 95
CA - Canada 85
AU - Australia 61
BD - Bangladesh 43
ID - Indonesia 41
JP - Giappone 40
AR - Argentina 24
EC - Ecuador 23
TR - Turchia 23
ZA - Sudafrica 23
NL - Olanda 22
CI - Costa d'Avorio 21
NG - Nigeria 21
MX - Messico 19
IQ - Iraq 18
ES - Italia 17
SC - Seychelles 16
CO - Colombia 13
MY - Malesia 12
UY - Uruguay 12
SA - Arabia Saudita 11
AT - Austria 10
PH - Filippine 10
VE - Venezuela 10
CL - Cile 9
IR - Iran 9
PY - Paraguay 9
BE - Belgio 8
CH - Svizzera 8
CR - Costa Rica 8
PK - Pakistan 8
EG - Egitto 6
KE - Kenya 6
MA - Marocco 6
NZ - Nuova Zelanda 6
BO - Bolivia 5
DO - Repubblica Dominicana 5
KZ - Kazakistan 5
LK - Sri Lanka 5
DK - Danimarca 4
KG - Kirghizistan 4
MD - Moldavia 4
TH - Thailandia 4
TN - Tunisia 4
UZ - Uzbekistan 4
AL - Albania 3
BJ - Benin 3
LT - Lituania 3
PE - Perù 3
RS - Serbia 3
AZ - Azerbaigian 2
CG - Congo 2
DZ - Algeria 2
IL - Israele 2
JM - Giamaica 2
LB - Libano 2
MM - Myanmar 2
NI - Nicaragua 2
OM - Oman 2
PS - Palestinian Territory 2
PT - Portogallo 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
GA - Gabon 1
GP - Guadalupe 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
LV - Lettonia 1
MK - Macedonia 1
MN - Mongolia 1
NP - Nepal 1
PA - Panama 1
PR - Porto Rico 1
Totale 16.371
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.945
Ashburn 757
Singapore 713
Hong Kong 554
Fairfield 479
Warsaw 347
San Jose 335
Dublin 331
Chandler 311
Seoul 284
Jacksonville 248
Woodbridge 210
Hefei 207
Seattle 191
Milan 188
Houston 185
Cambridge 171
Beijing 168
Florence 165
Wilmington 157
Dallas 153
Council Bluffs 140
Lawrence 128
Altamura 127
Los Angeles 117
Ho Chi Minh City 116
The Dalles 104
Lauterbourg 102
Princeton 100
Buffalo 99
Ann Arbor 91
Hanoi 79
Moscow 71
Rome 70
Medford 61
Melbourne 58
Boston 51
Mumbai 50
Boardman 47
Munich 43
San Diego 40
Chicago 39
Phoenix 39
São Paulo 38
Helsinki 37
Kent 33
Shanghai 31
New York 30
London 28
Jakarta 26
Toronto 25
Tokyo 24
Abidjan 21
Abuja 20
Atlanta 19
Lappeenranta 19
Redondo Beach 18
Norwalk 17
Cardiff 16
Naples 16
Rio de Janeiro 16
Clifton 15
Frankfurt am Main 15
Johannesburg 15
Bologna 14
Haiphong 14
Miano 14
Turin 13
Brooklyn 12
Frankfurt Am Main 12
Guangzhou 12
Hillsboro 12
Hải Dương 12
San Francisco 12
West Jordan 12
Chennai 11
Da Nang 11
Figino 11
Guayaquil 10
Orem 10
Palermo 10
Tianjin 10
Andover 9
Columbus 9
Izmir 9
Quito 9
Belo Horizonte 8
Bern 8
Brussels 8
Campinas 8
Catania 8
Dong Ket 8
Elk Grove Village 8
Montreal 8
Saint Petersburg 8
Siena 8
Turku 8
Auburn Hills 7
Bari 7
Bến Tre 7
Totale 10.707
Salva come PNG Salva come JPEG
Nome #
Reassortment ability of the 2009 pandemic H1N1 influenza virus with circulating human and avian influenza viruses: Public health risk implications 359
Markers of JC virus infection in patients with multiple sclerosis under natalizumab therapy. 338
Investigation of in vitro replication features of wild ducks and turkey H7N3 influenza viruses: possibile role in interspecies transmission. 269
COVID-19 Salivary Signature: Diagnostic and Research Opportunities 257
Extracellular vesicles engagement during respiratory viruses infection 229
Co-circulation of the two influenza B lineages during 13 consecutive influenza surveillance seasons in Italy, 2004-2017 224
Assessment of the risk of polyomavirus JC reactivation in patients with immune-mediated diseases during long-term treatment with infliximab 212
Polyomavirus microRNA in saliva reveals persistent infectious status in the oral cavity 209
SARS-CoV-2 inhibitory activity of a short peptide derived from internal fusion peptide of S2 subunit of spike glycoprotein 208
Antiviral activity against SARS-CoV-2 of conformationally constrained helical peptides derived from angiotensin-converting enzyme-2. 204
Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein. 198
Utility of droplet digital PCR for the quantitative detection of polyomavirus JC in clinical samples 196
Performance of at-home self-collected saliva and nasal-oropharyngeal swabs in the surveillance of COVID-19 195
Investigation on torquetenovirus (TTV) microRNA transcriptome in vivo 193
Blood levels of TT virus following immune stimulation with influenza or hepatitis B vaccine. 191
Characterization of human H1N1 influenza virus variants selected In vitro with zanamivir in the presence of sialic acid-containing molecules 191
Packaging signals in the 5'-ends of influenza virus PA, PB1, and PB2 genes as potential targets to develop nucleic-acid based antiviral molecules. 191
Detection of JCPyV microRNA in blood and urine samples of multiple sclerosis patients under natalizumab therapy. 190
The JCPYV DNA load inversely correlates with the viral microrna expression in blood and cerebrospinal fluid of patients at risk of PML 189
BK polyomavirus microRNA levels in exosomes are modulated by non-coding control region activity, and down-regulate viral replication when delivered to non-infected cells prior to infection. 188
Comparison of in vitro replication features of H7N3 influenza viruses from wild ducks and turkeys: potential implications for interspecies transmission. 187
High-resolution melting analysis for detection of nucleotide mutation markers in the polymerase-acidic (PA) gene of influenza virus that are associated with baloxavir marboxil resistance 186
Torquetenovirus (TTV) load is associated with mortality in Italian elderly subjects 186
AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: failure to protect and possible enhancement of challenge infection by four cell-based vaccines prepared with autologous lymphoblasts. 184
AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: reevaluation of neutralizing antibody levels elicited by a protective and a nonprotective vaccine after removal of antisubstrate cell antibodies. 183
A retro-inverso analogue of the antiviral octapeptide C8 inhibits feline immunodeficiency virus in serum. 181
Polyomavirus microRNAs circulating in biological fluids during viral persistence 179
Development of antiviral fusion inhibitors: short modified peptides derived from the transmembrane glycoprotein of feline immunodeficiency virus 177
The Emergence of Saliva as a Diagnostic and Prognostic Tool for Viral Infections 173
Moderate influenza vaccine effectiveness against A(H1N1)pdm09 virus, and low effectiveness against A(H3N2) subtype, 2018/19 season in Italy 170
DDX3X helicase inhibitors as new strategy to fight West Nile Virus infection. 169
AIDS vaccination studies using feline immunodeficiency virus as a model: immunisation with inactivated whole virus suppresses viraemia levels following intravaginal challenge with infected cells but not following intravenous challenge with cell-free virus. 167
Detection of Polyomavirus microRNA-5p Expression in Saliva Short-Term after Kidney Transplantation 166
West Nile virus seroprevalence in the Italian Tuscany region from 2016 to 2019 165
Vaccination with an inactivated virulent feline immunodeficiency virus engineered to express high levels of Env 164
Plasma Torquetenovirus (TTV) microRNAs and severity of COVID-19 163
Feline immunodeficiency virus plasma load reduction by a retroinverso octapeptide reproducing the Trp-rich motif of the transmembrane glycoprotein 162
Quantification of torque teno virus (TTV) DNA in saliva and plasma samples in patients at short time before and after kidney transplantation 162
Synthesis, conformational analysis and biological activity evaluation of novel antiviral peptides blocking the SARS-CoV-2 cell-entry 161
Antiviral activity of oligonucleotides targeting the SARS-CoV-2 genomic RNA stem-loop sequences within the 3’-end of the ORF1b. 161
Multiple signatures of the JC polyomavirus in paired normal and altered colorectal mucosa indicate a link with human colorectal cancer, but not with cancer progression. 160
AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: detailed analysis of the humoral immune response to a protective vaccine. 159
Archetype JC polyomavirus DNA associated with extracellular vesicles circulates in human plasma samples. 159
Detection of polyomavirus JC DNA and anti-JCV antibody in MS patients under natalizumab therapy. 158
Autologous and heterologous neutralization analyses of primary feline immunodeficiency virus isolates. 158
Are there lessons that can be learned from the FIV model ? 153
Oligonucleotides derived from the packaging signal at the 5’ end of the viral PB2 segment specifically inhibit influenza virus in vitro 153
High Resolution Melting (HRM) analysis for rapid risk assessment of reassortment of avian H5N1 influenza virus with circulating human influenza virus 151
Analisi dell’espressione di microRNA prodotti dal Polyomavirus JC. 150
Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: epitope definition and implications in risk stratification of patients under natalizumab therapy 149
Changes in the SU can modulate the susceptibility of feline immunodeficiency virus to TM-derived entry inhibitors. 149
Polyomavirus JC microRNAs expression after infection in vitro. 148
Torquetenovirus detection in exosomes enriched vesicles circulating in human plasma samples. 147
Dissection of seroreactivity against the tryptophan-rich motif of feline immunodeficiency virus transmembrane glycoprotein. 144
During readaptation in vivo, a tissue culture-adapted strain of feline immunodeficiency virus reverts to broad neutralization resistance at different times in individual hosts but through changes at the same position of the surface glycoprotein. 144
Identification of Novel Non-Nucleoside Inhibitors of Zika Virus NS5 Protein Targeting MTase Activity 143
The inhibition of a plant proteinase by lysine copolymers is modulated by the hydrophobicity of interposed amino acid side chains. 143
Unique domain for a unique target: selective inhibitors of host cell DDX3X to fight emerging viruses 143
Immunogenicity of an anti-clade B feline immunodeficiency fixed-cell virus vaccine in field cats. 143
AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: homologous erythrocytes as a delivery system for preferential immunization with putative protective antigens. 142
Molecular adaptation of an H7N3 wild duck influenza virus following experimental multiple passages in quail and turkey. 141
Feline immunodeficiency virus-infected cat sera associated with the development of broad neutralization resistance in vivo drive similar reversions in vitro. 139
Screening of the essential oil effects on human H1N1 influenza virus infection: an in vitro study in MDCK cells 139
A retroinverso peptide reproducing the Trp-rich motif of the FIV TM has favorable pharmacological traits and markedly reduces viral loads in a short-monotherapy experiment. 138
Investigation of Oral Shedding of Torquetenovirus (TTV) in Moderate-to-Severe COVID-19 Hospitalised Patients 135
The membrane-proximal tryptophan-rich region in the transmembrane glycoprotein ectodomain of feline immunodeficiency virus is important for cell entry. 135
INCUBATION TIME FOR FELINE IMMUNODEFICIENCY VIRUS CULTURES. 133
Small RNAs targeting the 5' end of the viral polymerase gene segments specifically interfere with influenza type A virus replication 133
Kinetics of replication of a partially attenuated virus and of the challenge virus during a three-year intersubtype feline immunodeficiency virus superinfection experiment in cats. 131
I segnali di packaging alle estremità 5’ della regione codificante dei geni PA, PB1, E PB2 del virus dell’influenza come potenziali bersagli per lo sviluppo di antivirali. 130
Physicochemical characterization of a peptide deriving from the glycoprotein gp36 of the Feline Immunodeficiency Virus and its lipoylated analogue in micellar systems. 130
Torque teno virus microRNA detection in cerebrospinal fluids of patients with neurological pathologies 129
Evolution of two amino acid positions governing broad neutralization resistence in a strain of feline immunodeficiency virus over 7 years of persistence in cats. 128
Role of Env in the resistance of feline immunodeficiency virus (FIV)-infected cats to superinfection by a second FIV, as determined using a chimeric virus 126
Increased pathogenicity and shedding in chickens of a wild bird origin LPAI virus of the H7N3 subtype following multiple in vivo passages in quail and turkey. 126
In vitro and ex vivo detection of human polyomavirus JC microRNA 125
In vitro selection of a human H1N1 influenza virus with zanamivir in presence of sialic acid-containing molecules changes its susceptibility to this inhibitor through substitutions in the neuraminidase and hemagglutinin. 123
Pancreas rejection after pandemic influenzavirus A(H1N1)vaccination or infection: a report of two cases 123
Factors associated with death due to severe acute respiratory syndrome caused by influenza: Brazilian population study. 121
SARS-CoV-2: What Can Saliva Tell Us? 121
Evidence of the mechanism by which polyomaviruses exploit the extracellular vesicle delivery system during infection 120
Packaging signals in the 5' coding region of influenza virus PA, PB1, and PB2 genes as potential target to develop oligonucleotide based antiviral molecole. 120
Antibodies generated in cats by a lipopeptide reproducing the MPER of the feline immunodeficiency virus TM enhance virus infectivity 119
Severe acute respiratory syndrome by influenza and factors associated with death in older adults: a population study: Factors associated with death due to influenza 118
Single-round virus replication assay for assisting the design of small molecules inhibiting HIV entry in host cells. 117
Lack of direct association between oral mucosal lesions and SARS-CoV- 2 in a cohort of patients hospitalised with COVID-19 117
Reduced sensitivity to strain-specific neutralization of laboratory-adapted feline immunodeficiency virus after one passage in vivo: association with amino acid substitutions in V4 region of the surface glycoprotein. 114
Sudies on AIDS vaccination using an ex vivo feline immunodeficiency virus model: protection conferred by a fixed-cell vaccine against cell-free and cell-associated challenge differs in duration and is not easily boosted. 113
Effect of enzymatic deglycosylation on feline immunodeficiency virus sensitivity to antibody-mediated neutralization. 111
Vaccination protects against in vivo-grown feline immunodeficiency virus even in the absence of detectable neutralizating antibodies. 110
MALDI-TOF mass spectrometry of saliva samples as a prognostic tool for COVID-19 110
Detection of polyomavirus JC DNA and anti-JCV antibody in MS patients under natalizumab therapy. 108
Selezione in vitro di varianti virali di virus dell’ influenza aviaria H7N3 dell’anatra in presenza di sialogangliosidi. 107
Volatiles and Antifungal-Antibacterial-Antiviral Activity of South African Salvia spp. Essential Oils Cultivated in Uniform Conditions 106
Development of new antivirals against the influenza type A viruses based on small RNAs targeting the packaging signal of the polymarases gene coding region. 102
Reduced Presence of SARS-CoV-2 microRNA-like Small RNA in the Serum of Patients with Post-Acute Sequelae SARS-CoV-2 Infection 99
Investigation of reassortment ability of pandemic H1N1 influenza virus with circulating human and avian influenza viruses. 97
New influenza virus type A (H1N1), isolated in Florence. 96
Erratum: Pancreas rejection after pandemic influenzavirus A(H1N1) vaccination or infection: A report of two cases (Transplant International (2011) 24 (e28)) 95
Polyomavirus JC detection in patients with rheumatic disease after a long-term treatment with infliximab. 94
Totale 15.652
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.222
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.222
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022556 0 0 65 14 25 20 27 25 22 37 126 195
2022/20231.602 154 318 53 91 120 272 202 62 234 17 53 26
2023/2024583 26 87 116 38 39 34 31 110 14 41 32 15
2024/20254.957 136 491 299 581 1.174 1.133 87 427 144 140 174 171
2025/20265.152 502 809 481 416 590 186 635 271 318 247 136 561
2026/2027717 178 319 220 0 0 0 0 0 0 0 0 0
Totale 16.594